NVision
About NVision
NVision
NVision was established as a spin-off from the University of Ulm’s Institute of Quantum Optics and Institute of Theoretical Physics, leveraging nitrogen-vacancy centers in diamond for quantum sensing applications in medical imaging. Founded by Prof. Fedor Jelezko, Prof. Martin Plenio, Prof. Alex Retzker, and Ilai Schwartz (CTO), with Dr. Sella Brosh serving as CEO. The company raised $30 million Series A in June 2023 to deploy quantum-powered hyperpolarizers for MRI imaging, enabling earlier cancer treatment assessment. NVision’s technology fundamentally changes medical MRI by dramatically improving sensitivity through dynamic nuclear polarization using NV centers in diamond. The company bridges quantum physics and clinical medicine.
Company Information
- Founded: 2015
- Country: Germany
- Website: https://www.nvision-imaging.com
- Categories: hardware, diamond, quantum sensing
Related Companies
Explore other quantum computing companies in similar categories or regions.
Company Information
⚠️ Important Disclaimer
Information for Educational Purposes Only: All information about NVision is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of NVision's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.